These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13711138)

  • 1. Antigenic variants of influenza A virus (PR8 strain). VI. Results of repeated passages of the same variant in mice immunized with monovalent homologous vaccine or polyvalent vaccine.
    HAMRE D; LOOSLI CG; EWERT RC
    J Infect Dis; 1961; 108():151-62. PubMed ID: 13711138
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic variants of influenza A virus (PR8 strain) III. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine.
    HAMRE D; LOOSLI CG; GERBER P
    J Exp Med; 1958 Jun; 107(6):829-44. PubMed ID: 13539308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic variants of influenza A virus (PR8 strain). IV. Serological characteristics of a second line of variants developed in mice given polyvalent vaccine.
    HAMRE D; LOOSLI CG; GERBER P
    J Exp Med; 1958 Jun; 107(6):845-55. PubMed ID: 13539309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic variants of influenza A virus (PR8 strain). II. Serological and immunological characteristics of variants derived from variants.
    GERBER P; HAMRE D; LOOSLI CG
    J Exp Med; 1956 Apr; 103(4):413-24. PubMed ID: 13306851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variants of influenza A virus (PR8 strain). V. Virulence, antigenic potency, and cross-protection tests in mice of the original and second series.
    LOOSLI CG; HAMRE D; GERBER P
    J Exp Med; 1958 Jun; 107(6):857-68. PubMed ID: 13539310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic variants of influenza A virus, PR8 strain. I. Their development during serial passage in the lungs of partially immune mice.
    GERBER P; LOOSLI CG; HAMBRE D
    J Exp Med; 1955 Jun; 101(6):627-38. PubMed ID: 14367684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine.
    DAVENPORT FM; HENNESSY AV
    J Exp Med; 1956 Jul; 104(1):85-97. PubMed ID: 13332182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.
    Naito T; Mori K; Ushirogawa H; Takizawa N; Nobusawa E; Odagiri T; Tashiro M; Ohniwa RL; Nagata K; Saito M
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
    Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model.
    Lipatov AS; Webby RJ; Govorkova EA; Krauss S; Webster RG
    J Infect Dis; 2005 Apr; 191(8):1216-20. PubMed ID: 15776365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
    Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
    Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic drift and efficacy of influenza virus vaccines, 1976--1977.
    Meiklejohn G; Eickhoff TC; Graves P; I J
    J Infect Dis; 1978 Nov; 138(5):618-24. PubMed ID: 712117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains.
    Kim JH; Liepkalns J; Reber AJ; Lu X; Music N; Jacob J; Sambhara S
    Vaccine; 2016 Jan; 34(4):495-502. PubMed ID: 26706277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum.
    ARCHETTI I; HORSFALL FL
    J Exp Med; 1950 Nov; 92(5):441-62. PubMed ID: 14778924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.